- Home
- QRHC vs HLVX Comparison
QRHC vs HLVX Comparison
Compare QRHC & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRHC
- HLVX
- Stock Information
- Founded
- QRHC N/A
- HLVX 2020
- Country
- QRHC United States
- HLVX United States
- Employees
- QRHC N/A
- HLVX N/A
- Industry
- QRHC Environmental Services
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- QRHC Utilities
- HLVX Health Care
- Exchange
- QRHC Nasdaq
- HLVX Nasdaq
- Market Cap
- QRHC 92.0M
- HLVX 83.7M
- IPO Year
- QRHC N/A
- HLVX 2022
- Fundamental
- Price
- QRHC $2.42
- HLVX $1.91
- Analyst Decision
- QRHC Strong Buy
- HLVX Hold
- Analyst Count
- QRHC 2
- HLVX 5
- Target Price
- QRHC $12.75
- HLVX $2.33
- AVG Volume (30 Days)
- QRHC 78.4K
- HLVX 298.1K
- Earning Date
- QRHC 05-12-2025
- HLVX 05-08-2025
- Dividend Yield
- QRHC N/A
- HLVX N/A
- EPS Growth
- QRHC N/A
- HLVX N/A
- EPS
- QRHC N/A
- HLVX N/A
- Revenue
- QRHC $288,532,000.00
- HLVX N/A
- Revenue This Year
- QRHC $7.55
- HLVX N/A
- Revenue Next Year
- QRHC $7.03
- HLVX N/A
- P/E Ratio
- QRHC N/A
- HLVX N/A
- Revenue Growth
- QRHC 0.05
- HLVX N/A
- 52 Week Low
- QRHC $1.91
- HLVX $1.34
- 52 Week High
- QRHC $10.51
- HLVX $16.31
- Technical
- Relative Strength Index (RSI)
- QRHC 45.56
- HLVX 61.71
- Support Level
- QRHC $2.14
- HLVX $1.81
- Resistance Level
- QRHC $2.51
- HLVX $1.94
- Average True Range (ATR)
- QRHC 0.21
- HLVX 0.10
- MACD
- QRHC 0.07
- HLVX 0.01
- Stochastic Oscillator
- QRHC 56.60
- HLVX 83.87
About QRHC Quest Resource Holding Corporation
Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.